clomiphene citrate treatment outcomes in taiwanese hypogonadal men: a single-center preliminary report

Clicks: 335
ID: 173118
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #47 of 280 articles by views in acta crystallographica section e

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 280 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Objective: We evaluated the treatment efficacy of clomiphene citrate (CC) in hypogonadal men. Methods: We retrospectively reviewed our patients with a diagnosis of hypogonadism who received CC treatment, and compared the pretreatment and post-treatment serum testosterone levels. Subjective patient improvements were recorded using the Androgen Deficiency in Aging Males questionnaire. Results: A total of 10 patients were included in our analysis. Mean serum testosterone level increase from 246 ± 76 ng/dL to 548 ± 281 ng/dL was noted after treatment (p < 0.01). Eight (80%) patients successfully reached a target serum testosterone level of > 400 ng/dL after treatment. Conclusion: CC is an effective alternative treatment for patients with hypogonadism.
Reference Key
tan2017urologicalclomiphene Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal acta crystallographica section e
Year 2017
DOI
10.1016/j.urols.2016.03.001
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.